1. According to CAPC, 1 in 20 US dogs tested positive for Lyme disease in 2024.

  2. CAPC is only estimated to capture 30% of positive cases. That puts Lyme positive dogs more than 1.7 million annually.

  3. First and only chimeric recombinant Lyme vaccine developed to protect against the diverse B. burgdorferi strains.

  4. Innovative technology minimizes extraneous proteins, resulting in a safe and minimally reactive vaccine.